OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative analysis of CEACAM1 expression in thin melanomas with and without regression
Luciana Nichita, Sabina Zurac, Alexandra Bastian, et al.
Oncology Letters (2019)
Open Access | Times Cited: 9
Luciana Nichita, Sabina Zurac, Alexandra Bastian, et al.
Oncology Letters (2019)
Open Access | Times Cited: 9
Showing 9 citing articles:
Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
Katsiaryna Marhelava, Zofia Pilch, Małgorzata Bajor, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1756-1756
Open Access | Times Cited: 127
Katsiaryna Marhelava, Zofia Pilch, Małgorzata Bajor, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1756-1756
Open Access | Times Cited: 127
High-dimensional mapping of human CEACAM1 expression on immune cells and association with melanoma drug resistance
Yu‐Hwa Huang, Charles H. Yoon, Amit Gandhi, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 7
Yu‐Hwa Huang, Charles H. Yoon, Amit Gandhi, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 7
Characteristics of Carcinoembryonic Antigen-Related Cell Adhesion Molecules and Their Relationship to Cancer
Ru-xue Ma, Jianrui Wei, Yan‐Wei Hu
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 7, pp. 939-948
Closed Access | Times Cited: 2
Ru-xue Ma, Jianrui Wei, Yan‐Wei Hu
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 7, pp. 939-948
Closed Access | Times Cited: 2
The prognostic significance of the clinical and histological parameters in primary cutaneous melanoma patients
Mihaela Antohe, Anastasia Coman, Gabriela Turcu, et al.
Medicine and Pharmacy Reports (2022)
Open Access | Times Cited: 9
Mihaela Antohe, Anastasia Coman, Gabriela Turcu, et al.
Medicine and Pharmacy Reports (2022)
Open Access | Times Cited: 9
Reporting regression in primary cutaneous melanoma. Part 1: history, histological criteria and pathogenesis
Alexander M. Cartron, Paola C. Aldana, Amor Khachemoune
Clinical and Experimental Dermatology (2020) Vol. 46, Iss. 1, pp. 28-33
Closed Access | Times Cited: 13
Alexander M. Cartron, Paola C. Aldana, Amor Khachemoune
Clinical and Experimental Dermatology (2020) Vol. 46, Iss. 1, pp. 28-33
Closed Access | Times Cited: 13
Antibody-Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers
Suresh Madheswaran, Neelakshi Mungra, Fleury Augustin Nsole Biteghe, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 21, Iss. 2, pp. 162-186
Closed Access | Times Cited: 4
Suresh Madheswaran, Neelakshi Mungra, Fleury Augustin Nsole Biteghe, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 21, Iss. 2, pp. 162-186
Closed Access | Times Cited: 4
A Preliminary Investigation on Plasma Cell Adhesion Molecules Levels by Protein Microarray Technology in Major Depressive Disorder
Wanying Liu, Yanqun Zheng, Fuxu Zhang, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 4
Wanying Liu, Yanqun Zheng, Fuxu Zhang, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 4
Is It Time to Supersede the Diagnostic Term “Melanoma In Situ with Regression?” A Narrative Review
Anna Colagrande, Giuseppe Ingravallo, Gerardo Cazzato
Dermatopathology (2023) Vol. 10, Iss. 1, pp. 120-127
Open Access | Times Cited: 1
Anna Colagrande, Giuseppe Ingravallo, Gerardo Cazzato
Dermatopathology (2023) Vol. 10, Iss. 1, pp. 120-127
Open Access | Times Cited: 1
